Cabot Corp (CBT) Shares Sold by Wedge Capital Management L L P NC

Share on StockTwits

Wedge Capital Management L L P NC lowered its holdings in Cabot Corp (NYSE:CBT) by 4.0% in the third quarter, HoldingsChannel reports. The firm owned 210,994 shares of the specialty chemicals company’s stock after selling 8,811 shares during the period. Wedge Capital Management L L P NC’s holdings in Cabot were worth $13,234,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Signition LP purchased a new stake in shares of Cabot in the second quarter valued at $234,000. Advisory Services Network LLC lifted its holdings in shares of Cabot by 943.5% in the second quarter. Advisory Services Network LLC now owns 3,882 shares of the specialty chemicals company’s stock valued at $255,000 after purchasing an additional 3,510 shares in the last quarter. Strs Ohio purchased a new stake in shares of Cabot in the second quarter valued at $349,000. Oakbrook Investments LLC lifted its holdings in shares of Cabot by 17.2% in the second quarter. Oakbrook Investments LLC now owns 5,790 shares of the specialty chemicals company’s stock valued at $358,000 after purchasing an additional 850 shares in the last quarter. Finally, Seven Eight Capital LP purchased a new stake in shares of Cabot in the third quarter valued at $370,000. Institutional investors own 85.74% of the company’s stock.

Shares of NYSE:CBT opened at $50.11 on Wednesday. The company has a quick ratio of 0.97, a current ratio of 1.51 and a debt-to-equity ratio of 0.49. Cabot Corp has a 1 year low of $46.63 and a 1 year high of $68.63. The firm has a market cap of $3.21 billion, a P/E ratio of 12.43, a PEG ratio of 1.01 and a beta of 1.50.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Monday, November 5th. The specialty chemicals company reported $1.00 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.09 by ($0.09). Cabot had a positive return on equity of 17.41% and a negative net margin of 4.46%. The firm had revenue of $850.00 million for the quarter, compared to analysts’ expectations of $856.76 million. During the same quarter in the prior year, the business posted $0.91 earnings per share. Cabot’s revenue was up 17.6% on a year-over-year basis. Analysts anticipate that Cabot Corp will post 4.71 earnings per share for the current year.

Cabot announced that its Board of Directors has initiated a stock buyback program on Monday, July 16th that permits the company to buyback $400.00 million in shares. This buyback authorization permits the specialty chemicals company to purchase up to 10.3% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s management believes its shares are undervalued.

In related news, SVP Brian A. Berube sold 13,448 shares of the stock in a transaction on Thursday, August 9th. The stock was sold at an average price of $65.43, for a total transaction of $879,902.64. Following the completion of the sale, the senior vice president now directly owns 52,127 shares in the company, valued at $3,410,669.61. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Nicholas S. Cross sold 16,000 shares of the stock in a transaction on Tuesday, August 21st. The stock was sold at an average price of $65.86, for a total value of $1,053,760.00. Following the sale, the insider now owns 48,597 shares of the company’s stock, valued at $3,200,598.42. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 89,448 shares of company stock valued at $5,860,779. 2.20% of the stock is owned by corporate insiders.

A number of analysts have recently issued reports on the company. ValuEngine lowered Cabot from a “sell” rating to a “strong sell” rating in a report on Thursday, November 1st. Loop Capital set a $82.00 target price on Cabot and gave the company a “buy” rating in a report on Tuesday, July 17th. TheStreet lowered Cabot from a “b” rating to a “c+” rating in a report on Friday, October 19th. Zacks Investment Research lowered Cabot from a “buy” rating to a “sell” rating in a report on Tuesday, October 16th. Finally, Barclays assumed coverage on Cabot in a report on Monday, October 8th. They issued an “overweight” rating and a $76.00 target price for the company. Two equities research analysts have rated the stock with a sell rating and six have given a buy rating to the stock. Cabot has an average rating of “Buy” and a consensus target price of $75.00.

ILLEGAL ACTIVITY WARNING: This story was first posted by Week Herald and is owned by of Week Herald. If you are viewing this story on another website, it was copied illegally and reposted in violation of U.S. and international copyright law. The original version of this story can be read at https://weekherald.com/2018/11/07/cabot-corp-cbt-shares-sold-by-wedge-capital-management-l-l-p-nc.html.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers carbon black, a form of elemental carbon used to enhance the physical properties of the systems and applications in which it is incorporated; and rubber blacks for use as a rubber reinforcing agent and performance additive in tires, hoses, belts, extruded profiles, and molded goods.

Further Reading: Insider Trading – What You Need to Know

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corp (NYSE:CBT).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply